Citation Tools
PDFRegular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
547 Reprogramming of type I interferon-responding tumor-reactive T lymphocytes associates with improved outcomes to neoadjuvant doublet immunotherapy in HNSCC
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 547 Reprogramming of type I interferon-responding tumor-reactive T lymphocytes associates with improved outcomes to neoadjuvant doublet immunotherapy in HNSCC